Related Experiment Video
Updated: Feb 27, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA methylation inhibitor causes cell growth retardation and gene expression changes in feline lymphoma cells
Maika Fujita1, Masahiro Kaneda1
1Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan.
Abstract:
DNA methylation is an epigenetic mechanism controlling gene expression without affecting DNA sequences, and aberrant DNA methylation patterns are features of a number of diseases. Notably, epigenetic errors in cancer cells have been intensively studied over the last two decades in humans; however, little is known concerning dogs and cats. To analyze DNA methylation and gene expression changes in feline lymphoma cells, we added the DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza) to three cell lines (3281 and FT-1 cells derived from T-cell lymphoma and MS4 cells derived from B-cell lymphoma). Adding 5-aza significantly retarded cell growth in a dose-dependent manner in all cell lines, and there were aberrant gene expression patterns. Transcription factor Sox11 expression in 3281 cells was de-repressed by 5-aza treatment, and subsequent promoter DNA demethylation was analyzed by bisulfite sequencing. Cell cycle analysis suggested that inhibition of cell growth was due to DNA replication arrest, and this supported the result of increased expression of p27kip1 gene which disturbed cells of 3281 and FT-1 entering the S phase. In this study, 5-aza suppressed the growth of feline lymphoma cells, but further experiments with normal lymph cells are necessary to confirm specificity of this drug treatment and to expand it for clinical use.
Insights
The DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza) suppressed feline lymphoma cell growth by causing DNA replication arrest. Aberrant gene expression patterns were observed, indicating potential therapeutic avenues for feline cancers.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Aberrant DNA methylation is linked to various diseases, particularly cancers.
- Epigenetic alterations in human cancers are well-studied, but less is known about canine and feline cancers.
- Feline lymphoma presents an opportunity to investigate epigenetic dysregulation in animal cancers.
Purpose of the Study:
- To investigate the effects of the DNA methylation inhibitor 5-aza-2 -deoxycytidine (5-aza) on feline lymphoma cell lines.
- To analyze DNA methylation and gene expression changes induced by 5-aza treatment.
- To explore the potential of epigenetic therapies for feline lymphoma.
Main Methods:
- Treatment of three feline lymphoma cell lines (T-cell: 3281, FT-1; B-cell: MS4) with varying doses of 5-aza.
- Cell growth assays to determine the dose-dependent effect of 5-aza.
- Gene expression analysis, including transcription factor Sox11 and cell cycle regulator p27kip1.
- Bisulfite sequencing to analyze DNA demethylation at specific gene promoters.
- Cell cycle analysis to understand the mechanism of growth inhibition.
Main Results:
- 5-aza significantly inhibited feline lymphoma cell growth in a dose-dependent manner across all tested cell lines.
- Aberrant gene expression patterns were observed following 5-aza treatment.
- Sox11 expression was de-repressed in 3281 cells, correlating with promoter DNA demethylation.
- Cell growth inhibition was attributed to DNA replication arrest, evidenced by increased p27kip1 expression.
Conclusions:
- 5-aza demonstrates suppressive effects on feline lymphoma cell growth, suggesting its potential as a therapeutic agent.
- The observed effects involve modulation of DNA methylation and gene expression, including cell cycle regulators.
- Further research involving normal feline lymphocytes is crucial to confirm drug specificity and explore clinical applications.
More Related Videos
11:53An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...